SCHEMBL8902184

SCHEMBL8902184

COOC(OC(C)C)C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
CA14 Q9ULX7 2/20 0.35
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28185729 0.85 SMN1; SMN2 (0.44) SMN1; SMN2CA14CA12
SCHEMBL8902179 0.81 SMN1; SMN2 (0.41) SMN1; SMN2CA14CA12
SCHEMBL6651370 0.70 SMN1; SMN2 (0.44) SMN1; SMN2CA14CA12
SCHEMBL20399902 0.70 SMN1; SMN2 (0.44) SMN1; SMN2CA14CA12
SCHEMBL31069720 0.70 SMN1; SMN2 (0.44) SMN1; SMN2CA14CA12
SCHEMBL18070189 0.70
SCHEMBL6651376 0.70 SMN1; SMN2 (0.44) SMN1; SMN2CA14CA12
SCHEMBL11416005 0.67 SMN1; SMN2 (0.43) SMN1; SMN2CA14CA12
SCHEMBL7717304 0.67 SMN1; SMN2 (0.41) SMN1; SMN2CA14CA12
SCHEMBL27658386 0.67 SMN1; SMN2 (0.41) SMN1; SMN2CA14CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed
EP-0533744-A1 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1993-03-31 EP disclosed
WO-1991019725-A2 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1991-12-26 WO disclosed